A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
April 30, 2024
Primary Completion Date
May 24, 2024
Study Completion Date
May 24, 2024
Conditions
Healthy Participants
Interventions
DRUG
Brensocatib Oral Solution
Brensocatib solution
DRUG
Brensocatib Oral Tablet
Brensocatib tablet
Trial Locations (1)
75230
USA001, Dallas
All Listed Sponsors
lead
Insmed Incorporated
INDUSTRY
NCT06344728 - A Study to Assess the Relative Bioavailability of Brensocatib Pediatric Oral Solution to Oral Tablets in Healthy Participants | Biotech Hunter | Biotech Hunter